These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 25758165)
1. Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation. Wagenaar TR; Zabludoff S; Ahn SM; Allerson C; Arlt H; Baffa R; Cao H; Davis S; Garcia-Echeverria C; Gaur R; Huang SM; Jiang L; Kim D; Metz-Weidmann C; Pavlicek A; Pollard J; Reeves J; Rocnik JL; Scheidler S; Shi C; Sun F; Tolstykh T; Weber W; Winter C; Yu E; Yu Q; Zheng G; Wiederschain D Mol Cancer Res; 2015 Jun; 13(6):1009-21. PubMed ID: 25758165 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1. Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
4. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma. Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase. Chang RM; Yang H; Fang F; Xu JF; Yang LY Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma. Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma. Que KT; Zhou Y; You Y; Zhang Z; Zhao XP; Gong JP; Liu ZJ J Exp Clin Cancer Res; 2018 Nov; 37(1):268. PubMed ID: 30400960 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1. Dou C; Wang Y; Li C; Liu Z; Jia Y; Li Q; Yang W; Yao Y; Liu Q; Tu K Oncotarget; 2015 May; 6(15):13216-28. PubMed ID: 25965836 [TBL] [Abstract][Full Text] [Related]
9. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma. El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824 [TBL] [Abstract][Full Text] [Related]
10. Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo. Fujita K; Iwama H; Sakamoto T; Okura R; Kobayashi K; Takano J; Katsura A; Tatsuta M; Maeda E; Mimura S; Nomura T; Tani J; Miyoshi H; Morishita A; Yoneyama H; Yamana Y; Himoto T; Okano K; Suzuki Y; Niki T; Hirashima M; Masaki T Int J Oncol; 2015; 46(6):2419-30. PubMed ID: 25823465 [TBL] [Abstract][Full Text] [Related]
11. Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth. Huang X; Magnus J; Kaimal V; Karmali P; Li J; Walls M; Prudente R; Sung E; Sorourian M; Lee R; Davis S; Yang X; Estrella H; Lee EC; Chau BN; Pavlicek A; Zabludoff S Mol Cancer Ther; 2017 May; 16(5):905-913. PubMed ID: 28167506 [TBL] [Abstract][Full Text] [Related]
12. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin. Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4. Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743 [TBL] [Abstract][Full Text] [Related]
14. MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients. Yuan B; Liang Y; Wang D; Luo F Cancer Sci; 2015 Jul; 106(7):819-24. PubMed ID: 25940592 [TBL] [Abstract][Full Text] [Related]
15. Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells. Dong YW; Wang R; Cai QQ; Qi B; Wu W; Zhang YH; Wu XZ J Hepatol; 2014 Apr; 60(4):792-801. PubMed ID: 24333181 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK). Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365 [TBL] [Abstract][Full Text] [Related]
17. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway. Gu W; Li X; Wang J Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507 [TBL] [Abstract][Full Text] [Related]
18. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β. Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010 [TBL] [Abstract][Full Text] [Related]
20. miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells. Gailhouste L; Gomez-Santos L; Hagiwara K; Hatada I; Kitagawa N; Kawaharada K; Thirion M; Kosaka N; Takahashi RU; Shibata T; Miyajima A; Ochiya T Hepatology; 2013 Sep; 58(3):1153-65. PubMed ID: 23532995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]